Evidence map›Paper›PMID 41121241›Full record

ArticleWorld journal of surgical oncology2025

Tumor invasion loci in resected margins of perihilar cholangiocarcinoma and their impact on survival: a retrospective 13-year longitudinal cohort study.

Yury Kovalenko, Anna Olifir, Andrei Glotov, Anatoly Popov, Sergey Trifonov, Dmitry Blagovestnov, Tatyana Shevchenko, Beslan Gurmikov, Nina Loginova, Yury Zharikov

Abstract read
In one paragraph

Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yury KovalenkoA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID https://orcid.org/0000-0001-9879-6403
Anna OlifirA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID http://orcid.org/0000-0002-1788-9681
Andrei GlotovA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID http://orcid.org/0000-0002-6904-9318
Anatoly PopovA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID https://orcid.org/0000-0001-6267-8237
Sergey TrifonovA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID https://orcid.org/0000-0003-1176-1203
Dmitry BlagovestnovRussian Medical Academy of Continuous Professional Education, Moscow, Russia.ORCID http://orcid.org/0000-0001-5724-6034
Tatyana ShevchenkoA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID http://orcid.org/0000-0003-4643-0252
Beslan GurmikovA.V. Vishnevsky National Medical Research Center, Moscow, Russia.ORCID http://orcid.org/0000-0001-5958-3608
Nina LoginovaFSAEI HE I.M. Sechenov First MSMU of MOH of Russia (Sechenovskiy University), Mokhovaya Street 11s10, Moscow, 125009, Russia.ORCID http://orcid.org/0009-0002-7631-8149
Yury ZharikovFSAEI HE I.M. Sechenov First MSMU of MOH of Russia (Sechenovskiy University), Mokhovaya Street 11s10, Moscow, 125009, Russia. dr_zharikov@mail.ru.ORCID http://orcid.org/0000-0001-9636-3807

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPerihilar cholangiocarcinoma (PHC) presents significant challenges in achieving curative resection, with current definitions of radicality (R0/R1/R2) based solely on tumor presence at margins lacking prognostic precision. This study investigates the impact of tumor invasion loci within resection margins on survival and proposes a novel RN0-7 system.

methodsA 13-year retrospective cohort study of 83 PHC patients undergoing liver/bile duct resection was conducted. Histopathological evaluation assessed seven invasion loci: bile duct margins, adipose tissue, hepatic parenchyma, vascular/lymphatic structures, perineural spaces, lymph nodes, and radial margins. Margin status was redefined as RN0-7, combining the number of tumor-positive loci (R + 1 to R + 6) with lymph node status (N). Survival analysis utilized Kaplan-Meier and Cox regression methods.

resultsTumor invasion loci were identified in 91.6% of specimens. Multivariate analysis revealed perineural invasion (HR = 14.48, p = 0.03), lymph node involvement (HR = 2.16, p = 0.01), and higher TNM stage (p = 0.006) as key prognostic factors. Survival rates declined progressively with increasing invasion loci: 5-year survival exceeded 60 months for patients with ≤ 2 loci (RN0-2), but dropped significantly with ≥ 3 loci (p < 0.00001). Traditional UICC R0/R1 system poorly correlated with outcomes, as 36.1% classified as R0 exhibited poor survival if multiple loci were involved.

conclusionRN0-7 system based on the number of tumor invasion loci in resection margins, combined with lymph node status, provides superior prognostic stratification compared to conventional R0/R1 criteria. The invasion loci were selected based on the principle of «assessing tumor infiltration in all anatomical structures within the true resection margin». In our opinion, this approach allowed us to gain a complete understanding (to the best of our ability) of how the “purity” of the resection margin affects survival. This RN0-7 system highlights the importance of quantifying anatomical sites of residual disease, offering a foundation for standardized histopathological evaluation and may have potential significance. This approach may enhance prognostic accuracy and guide therapeutic decisions in PHC, where randomized trials remain impractical.

Indexed as

Bile Duct NeoplasmsHepatectomyKlatskin TumorMargins of ExcisionAgedFemaleFollow-Up StudiesHumansLongitudinal StudiesLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingPrognosisRetrospective StudiesPerihilar cholangiocarcinomaPrognostic systemRadicalityResection marginSurvival analysisTumor invasion loci

Identifiers

PMID41121241
PMCPMC12538948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.